Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBTLE: Belimumab in SLE
NCT04447053Phase 4Unknown
- Sponsor
- National University Hospital
- Start
- Nov 2021
- Primary completion
- May 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by National University Hospital. Status: unknown.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04447053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447053.